Agilon Health (AGL) Receivables (2020 - 2026)

Agilon Health has reported Receivables for 7 years, with the latest figure at $899.7 million in Q1 2026.

• For the quarter ending Q1 2026, Receivables fell 27.42% year-over-year to $899.7 million; the trailing twelve-month figure through Mar 2026 stood at $899.7 million (down 27.42% YoY), and the FY2025 full-year result was $673.8 million, down 33.75% from the prior year.
• Receivables for Q1 2026 stood at $899.7 million, up from $673.8 million in the prior quarter.
• The five-year high for Receivables was $1.6 billion in Q1 2024, with the low at $499.3 million in Q4 2022.
• Historically, Receivables has averaged $1.0 billion across 5 years, with a median of $1.0 billion in 2023.
• Annual changes were most pronounced in 2023 — Receivables jumped 133.21% — and 2025, when it tumbled 33.75%.
• Agilon Health's Receivables stood at $499.3 million in 2022, then surged by 89.69% to $947.1 million in 2023, then increased by 7.39% to $1.0 billion in 2024, then plunged by 33.75% to $673.8 million in 2025, then jumped by 33.53% to $899.7 million in 2026.
• The last three Receivables figures came in at $899.7 million (Q1 2026), $673.8 million (Q4 2025), and $947.2 million (Q3 2025), per Business Quant data.